| Literature DB >> 26537711 |
R Wiklund1,2, A Toots3,4, M Conradsson3, B Olofsson5,6, H Holmberg7, E Rosendahl3,4, Y Gustafson3, H Littbrand3,4.
Abstract
SUMMARY: Knowledge of risk factors for hip fracture among very old people is limited. Walking indoors with help from ≤1 person, Parkinson's disease, currently smoking, delirium in the previous month, underweight, and age were associated with increased risk of hip fracture and could be important for preventive strategy development.Entities:
Keywords: Dementia; Hip fracture; Independent living; Residential facility; Risk factor; Very old
Mesh:
Year: 2015 PMID: 26537711 PMCID: PMC4767860 DOI: 10.1007/s00198-015-3390-9
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507
Fig. 1Flow chart of study sample
Baseline characteristics for the total sample and participants with hip fracture during follow-up, as well as hazard ratios (HR) for hip fracture during follow-up
| Characteristic | Total sample ( | Hip fracture cases ( | HR (95 % CI) |
|
|---|---|---|---|---|
| Age (years) | 89.3 ± 4.7 | 89.8 (4.3) | 1.07 (1.02–1.11) | 0.004 |
| Age group (years) | 0.001 | |||
| 85 | 434 (45.5) | 32 (33.3) | ||
| 90 | 293 (30.8) | 44 (45.8) | 2.31 (1.47–3.65) | <0.001 |
| ≥95 | 225 (23.6) | 20 (20.8) | 2.01 (1.14–3.55) | 0.016 |
| Women | 627 (65.8) | 65 (67.7) | 0.99 (0.64–1.52) | 0.957 |
| Living in residential care facility | 351 (36.8) | 38 (39.6) | 1.81 (1.20–2.74) | 0.005 |
| Living alone | 757 (79.4) | 78 (81.3) | 1.27 (0.76–2.12) | 0.357 |
| Currently smoking ( | 29 (3.1) | 6 (6.3) | 2.88 (1.40–5.96) | 0.004 |
| History of smoking ( | 330 (35.0) | 33 (35.9) | 1.02 (0.67–1.57) | 0.912 |
| History of ≥1 fall previous year ( | 423 (46.9) | 53 (56.4) | 1.58 (1.05–2.37) | 0.029 |
| Medical diagnoses and conditions | ||||
| History of any fracture | 501 (52.6) | 53 (55.2) | 1.22 (0.82–1.82) | 0.333 |
| History of hip fracture | 194 (20.4) | 21 (21.9) | 1.37 (0.85–2.23) | 0.200 |
| Osteoporosis | 309 (32.4) | 32 (33.3) | 1.14 (0.75–1.75) | 0.533 |
| Hip prosthesisa | 114 (12.0) | 6 (6.3) | 0.43 (0.19–0.99) | 0.048 |
| Dementia | 320 (33.6) | 28 (29.2) | 1.33 (0.85–2.08) | 0.213 |
| Delirium in the previous month | 206 (21.6) | 21 (21.9) | 1.84 (1.12–3.00) | 0.016 |
| Depressive disorder | 335 (35.2) | 33 (34.4) | 1.20 (0.78–1.82) | 0.407 |
| Parkinson’s disease | 15 (1.6) | 4 (4.2) | 3.35 (1.23–9.13) | 0.018 |
| Cerebrovascular disease | 206 (21.6) | 13 (13.5) | 0.60 (0.33–1.07) | 0.082 |
| Heart failure | 272 (28.5) | 21 (21.9) | 0.94 (0.58–1.53) | 0.796 |
| Diabetes | 148 (15.5) | 15 (15.6) | 1.12 (0.64–1.94) | 0.693 |
| Rheumatoid arthritis | 118 (12.4) | 10 (10.4) | 0.79 (0.41–1.53) | 0.486 |
| Osteoarthritis—lower extremities ( | 317 (33.5) | 21 (22.1) | 0.57 (0.35–0.93) | 0.023 |
| Malignancy in the previous 5 years | 116 (12.2) | 13 (13.5) | 1.42 (0.79–2.56) | 0.239 |
| Thyroid disease | 137 (14.4) | 13 (13.5) | 0.87 (0.49–1.57) | 0.649 |
| ≥1 urinary infection in previous year | 234 (24.6) | 16 (16.7) | 0.68 (0.40–1.16) | 0.156 |
| Routine prescription medications | ||||
| Benzodiazepines | 231 (24.2) | 23 (24.0) | 0.98 (0.61–1.56) | 0.927 |
| Beta-blockers | 303 (31.8) | 28 (29.2) | 0.91 (0.58–1.41) | 0.662 |
| Selective serotonin reuptake inhibitors | 123 (12.9) | 18 (18.8) | 1.77 (1.06–2.96) | 0.029 |
| Diuretics | 480 (50.4) | 35 (36.5) | 0.63 (0.41–0.95) | 0.028 |
| Analgesics | 416 (43.7) | 43 (44.8) | 1.24 (0.83–1.85) | 0.299 |
| Paracetamol | 346 (36.3) | 37 (38.5) | 1.37 (0.91–2.07) | 0.133 |
| Non-steroidal anti-inflammatory drugs | 61 (6.4) | 5 (5.2) | 0.68 (0.28–1.68) | 0.407 |
| Opioids | 141 (14.8) | 17 (17.7) | 1.38 (0.82–2.33) | 0.228 |
| Levothyroxine sodium | 103 (10.8) | 12 (12.5) | 1.15 (0.63–2.10) | 0.657 |
| Neuroleptics | 110 (11.6) | 10 (10.4) | 1.05 (0.55–2.03) | 0.874 |
| Cortisone (oral) | 121 (12.7) | 7 (7.3) | 0.55 (0.26–1.19) | 0.129 |
| Systemic estrogen treatment | 143 (15.0) | 12 (12.5) | 0.77 (0.42–1.41) | 0.401 |
| Number of routine prescription medications | 6.6 ± 4.1 | 5.9 ± 3.7 | 0.98 (0.93–1.03) | 0.474 |
| Assessments | ||||
| Vision impairment ( | 174 (18.9) | 19 (20.2) | 1.48 (0.89–2.45) | 0.130 |
| Barthel ADL Index (0–20; | 16.4 ± 5.5 | 17.6 ± 3.5 | 1.00 (0.96–1.05) | 0.962 |
| Walking indoors with help of no more than one person ( | 838 (88.5) | 92 (96.8) | 2.48 (0.78–7.84) | 0.123 |
| Independent in instrumental ADL ( | 218 (23.0) | 21 (22.1) | 0.66 (0.40–1.07) | 0.092 |
| Body mass index (BMI), mean ± SD ( | 25.2 ± 4.4 | 25.0 ± 4.8 | 0.97 (0.93–1.02) | 0.263 |
| Underweight (BMI < 22; | 200 (22.1) | 26 (28.0) | 1.72 (1.09–2.70) | 0.020 |
| Mini-Mental State Examination (0–30; | 21.2 (7.6) | 21.4 ± 7.3 | 0.97 (0.94–1.00) | 0.022 |
| Mini-Nutritional Assessment Scale (0–30; | 23.7 (4.2) | 24.1 (3.2) | 0.92 (0.86–0.98) | 0.007 |
| Able to rise from a chair independently without using hands ( | 575 (61.2) | 59 (64.8) | 0.74 (0.48–1.15) | 0.182 |
Data are presented as mean ± standard deviation or n (%). Univariate Cox proportional hazard regression was used to analyze associations between baseline characteristics and time to first hip fracture during follow-up
CI confidence interval, ADL activities of daily living, BMI body mass index
aFor the 114 participants with unilateral (n = 82) or bilateral (n = 32) hip prostheses
bAccording to Barthel ADL Index item 7
cAccording to ADL staircase
dHazard ratio during the first 500 days of follow-up only since the assumption of time independency was not fulfilled in total follow-up of 1827 days
Sex- and age-specific hip fracture incidence rates
| Age group (years) | Participants with follow-up hip fracture (cervical/trochanteric) | Person-years | Hip fractures per 100,000 person-years |
|---|---|---|---|
| Women | 65 (26/39) | 1765 | 3683 |
| 85 | 20 (9/11) | 873 | 2291 |
| 90 | 28 (10/18) | 542 | 5166 |
| 95+ | 17 (7/10) | 351 | 4843 |
| Men | 31 (22/9) | 834 | 3717 |
| 85 | 12 (11/1) | 465 | 2581 |
| 90 | 16 (10/6) | 274 | 5839 |
| 95+ | 3 (1/2) | 96 | 3125 |
| Total | 96 (48/48) | 2599 | 3694 |
Hazard ratios for hip fracture in the multivariate Cox proportional hazard regression model
| Characteristics | Hazard ratio | 95 % CI |
|
|---|---|---|---|
| Walking indoors with help from no more than one person | 8.57 | 1.90–38.71 | 0.005 |
| Parkinson’s disease | 5.12 | 1.82–14.44 | 0.002 |
| Currently smoking | 4.38 | 2.06–9.33 | <0.001 |
| Delirium in previous month | 2.01 | 1.15–3.49 | 0.014 |
| Underweight (BMI <22.0) | 1.74 | 1.09–2.77 | 0.020 |
| Age | 1.09 | 1.04–1.14 | 0.001 |
| Hip prosthesis | 0.37 | 0.15–0.91 | 0.031 |
| Female sex | 0.875 | 0.56–1.37 | 0.557 |
CI confidence interval, BMI body mass index